Bowman L C, Houghton J A, Houghton P J
Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101.
J Cell Physiol. 1990 Sep;144(3):376-82. doi: 10.1002/jcp.1041440303.
In cytosols from human rhabdomyosarcoma xenografts, the formation of vincristine (VCR)-tubulin complex and its stability were increased by GTP (Bowman et al.: Biochem. Biophys. Res. Commun., 135:695-700, 1986). We have further examined this modulation to determine whether a) GTP was protecting the VCR binding site from denaturation, b) the enhancement of complex formation was guanosine specific, and c) whether this influence was a direct interaction between GTP, VCR, and tubulin, or was mediated through another factor. In GTP-depleted cytosols from tumor xenografts HxRH18 and HxRh12, VCR binding activity was stable for at least 2 hours at 37 degrees C, indicating that the enhancement of complex formation and stability was not due to protection of tubulin integrity as measured by VCR binding; 10 nM GTP increased complex formation slightly, with complex formation increasing as GTP concentrations were increased to 5 microM, where maximum effect was observed. GTP and GDP (0.1 mM) both increased complex formation three-fold, while GMP, GMP-PNP, and ITP increased formation 1.5-fold. IMP, CTP, and ATP had no significant effect. Therefore, the modulation of VCR binding was relatively specific for the guanine nucleotides GDP and GTP. Microtubule protein, purified from Rh18 and Rh12 tumors by cycles of polymerization-depolymerization, bound VCR rapidly and binding was not influenced by GTP. This suggested that GTP modulation of VCR binding in cytosols was through a soluble factor lost in tubulin purification. In experiments with cytosol fractionated by molecular weight, there was inhibition of VCR binding activity by fractions with an mw range 20-50 kD. This inhibition was decreased by 25% by the addition of GTP. These data suggest that in tumor cytosols there may be competition between VCR and a natural ligand that is modulated by GTP. Two potential models for VCR binding are proposed.
在人横纹肌肉瘤异种移植瘤的胞质溶胶中,鸟苷三磷酸(GTP)可增加长春新碱(VCR)-微管蛋白复合物的形成及其稳定性(鲍曼等人:《生物化学与生物物理研究通讯》,135:695 - 700,1986年)。我们进一步研究了这种调节作用,以确定:a)GTP是否在保护VCR结合位点免受热变性影响;b)复合物形成的增强是否具有鸟苷特异性;c)这种影响是GTP、VCR和微管蛋白之间的直接相互作用,还是通过另一种因子介导的。在来自肿瘤异种移植瘤HxRH18和HxRh12的GTP耗尽的胞质溶胶中,VCR结合活性在37℃下至少2小时保持稳定,这表明复合物形成和稳定性的增强并非由于VCR结合所检测到的微管蛋白完整性的保护;10 nM GTP使复合物形成略有增加,随着GTP浓度增加到5 microM,复合物形成增加,此时观察到最大效应。GTP和鸟苷二磷酸(GDP)(0.1 mM)均使复合物形成增加了三倍,而鸟苷一磷酸(GMP)、鸟苷5'-三磷酸(GMP-PNP)和肌苷三磷酸(ITP)使形成增加了1.5倍。肌苷一磷酸(IMP)、胞苷三磷酸(CTP)和腺苷三磷酸(ATP)无显著影响。因此,VCR结合的调节对鸟嘌呤核苷酸GDP和GTP具有相对特异性。通过聚合 - 解聚循环从Rh18和Rh12肿瘤中纯化的微管蛋白能快速结合VCR,且结合不受GTP影响。这表明胞质溶胶中GTP对VCR结合的调节是通过微管蛋白纯化过程中丢失的一种可溶性因子介导的。在分子量分级分离胞质溶胶的实验中,分子量范围为20 - 50 kD的组分对VCR结合活性有抑制作用。加入GTP后,这种抑制作用降低了25%。这些数据表明,在肿瘤胞质溶胶中,VCR与一种受GTP调节的天然配体之间可能存在竞争。提出了两种VCR结合的潜在模型。